论文部分内容阅读
美国加利福尼亚州卡尔梅尔消息:圣地亚哥加利福尼亚大学(UCSD)的研究证明,一次用药治疗老年妇女膀胱炎“相对无效”。 J Edward Jackson在美国临床研究协会会议上说,在UCSD只有三分之一老年膀胱炎病人一次用甲氧苄氨嘧啶-磺胺甲基异噁唑(TMP-SMX)治疗取得疗效。但在年轻膀胱炎病人,报告的有效率高达93％。 Jackson说,治疗的失败不能归咎于对抗生素有耐药性,因为在联合用药5～7天这些药是很有效的”。 UCSD研究组包括18名年龄为62～87岁、能行动的膀胱炎病人。症状有尿频、排尿困难和下腹部痛,以及正常情况下不失禁的病人出现短暂的失禁。病人均无泌尿道感染复发史、尿道异常、肾石病、确诊的或可疑的肾病,在以前6周内没有因任何原因进行过抗生素治疗。
CARMEL, Calif., USA: Studies by the University of California, San Diego (UCSD) have shown that one-time treatment of cystitis in older women is “relatively ineffective.” J Edward Jackson at the American Society for Clinical Research Association meeting said that one third of patients with cystitis in the UCSD were treated with trimethoprim-sulfamethoxazole (TMP-SMX). However, in younger patients with cystitis, the reported rate of up to 93%. Jackson said the failure of treatment should not be attributed to antibiotic resistance because these drugs are effective 5-7 days of combination therapy. "The UCSD study group included 18 patients with age-active cystitis of 62 to 87 years Patients with frequent urination, dysuria, and lower abdominal pain, and transient incontinence in normal non-incontinent patients None of the patients had a history of recurrence of urinary tract infection, urinary tract abnormalities, nephrolithiasis, diagnosed or suspected nephropathy, There was no antibiotic treatment for any reason within the previous 6 weeks.